Company intelligence / Profile preview

A2-Ai

Ann Arbor, Michigan, United Statesa2-ai.com ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

A2-Ai is a full-service consultancy specializing in accelerating drug development for pharmaceutical companies. It provides expert support in clinical pharmacology, pharmacometrics (PK/PD), dose selection strategies for early-phase trials (including IND packages and first-in-human studies), as well as quantitative analyses for late-phase projects to support NDA/BLA submissions. The team has experience across multiple therapeutic areas with particular strength in oncology. They offer data-driven methods to optimize dosing regimens and regulatory documentation support.

Therapeutic areas: OncologyEndocrinologyImmunologyNeurologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Consulting

Beyond the preview

Go deeper on A2-Ai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on A2-Ai.

Explore the full profile